SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-133222
Filing Date
2020-12-08
Accepted
2020-12-08 16:35:50
Documents
14
Period of Report
2020-12-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2035841d1_8k.htm   iXBRL 8-K 24759
2 EXHIBIT 99.1 tm2035841d1_ex99-1.htm EX-99.1 20894
6 GRAPHIC tm2037953d1_ex99-1img001.jpg GRAPHIC 19142
  Complete submission text file 0001104659-20-133222.txt   254045

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA albo-20201208.xsd EX-101.SCH 3201
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE albo-20201208_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE albo-20201208_pre.xml EX-101.PRE 22720
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2035841d1_8k_htm.xml XML 3598
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 201375766
SIC: 2834 Pharmaceutical Preparations